Hyewon Ko Selected Research

Hyewon Ko Research Topics

23	Neoplasms (Cancer) 01/2023 - 06/2013
1	Rheumatoid Arthritis 01/2021
1	Experimental Arthritis 01/2021
1	Pulmonary Arterial Hypertension 01/2021
1	Necrosis 04/2020
1	Liver Diseases (Liver Disease) 01/2019
1	Hypophysitis 01/2019
1	Hypoxia (Hypoxemia) 04/2018
1	Triple Negative Breast Neoplasms 04/2018

5	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2018 - 06/2013
4	Drug CarriersIBA 11/2019 - 02/2015
4	GoldIBA 10/2018 - 12/2015
4	Hyaluronic Acid (Hyaluronan)IBA 01/2016 - 06/2013
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 10/2016
3	carboxymethyl dextranIBA 04/2018 - 05/2016
2	Peptides (Polypeptides)IBA 01/2023 - 01/2018
2	Immune Checkpoint InhibitorsIBA 01/2022 - 04/2020
2	Ethylene Glycol (Monoethylene Glycol)IBA 11/2018 - 06/2013
2	DisulfidesIBA 04/2018 - 02/2015
2	PolymersIBA 04/2018 - 04/2016
2	MicellesIBA 10/2016 - 02/2015
1	Antiviral Agents (Antivirals)IBA 01/2023
1	SulfonamidesIBA 01/2022
1	Sulfisoxazole (Sulfafurazole)FDA Link 01/2022
1	Endothelin Receptor AntagonistsIBA 01/2021
1	macitentanIBA 01/2021
1	EnzymesIBA 04/2020
1	CaspasesIBA 04/2020
1	Protein Kinases (Protein Kinase)IBA 04/2020
1	Cytotoxins (Cytolysins)IBA 01/2019
1	Dextrans (Dextran)FDA Link 11/2018
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2018
1	Vasodilator Agents (Vasodilators)IBA 11/2018
1	EstersIBA 10/2018
1	Glycoproteins (Glycoprotein)IBA 04/2018
1	Biomarkers (Surrogate Marker)IBA 04/2018
1	Histocompatibility Antigens Class IIBA 01/2018
1	OvalbuminIBA 01/2018
1	Stimuli Responsive PolymersIBA 01/2018
1	AntigensIBA 01/2018
1	AutoantigensIBA 01/2018
1	glycol-chitosanIBA 12/2017
1	Docetaxel (Taxotere)FDA Link 05/2016
1	BuffersIBA 05/2016
1	Small Interfering RNA (siRNA)IBA 12/2015
1	polycaprolactoneIBA 02/2015
1	IonsIBA 06/2013
1	Phosphates (Orthophosphate)IBA 06/2013
1	CalciumIBA 06/2013

15	Therapeutics 01/2021 - 02/2015
4	Immunotherapy 01/2023 - 01/2018
1	Intravenous Administration 01/2021
1	Drug Therapy (Chemotherapy) 01/2018
1	Precision Medicine 12/2017